Table of Contents
I. May 18th, 2011 Deadline for Call For Invited Posters for NIDA and NIAAA Genetics Satellite Miniconvention to World Congress on Psychiatric Genetics, Sept. 9-10, 2011, Omni Shoreham Hotel, Washington, DC
II. NIDA Satellite Meeting at CPDD: Fundamental Genetics in Drug Abuse and Addiction, Friday, June 17, 2011, 8:00 AM - 4:00 PM
III. Save the Date for NIDA Mini-Convention
IV. Upcoming Request for Applications (RFAs)
V. Advanced Medical Imaging Developments and Applications for Neuroscience Research
VI. Website Available for Studying Co-expression Patterns of Genes Implicated in Addiction: Leveraging the genome-scale, high resolution expression maps created within the Allen Mouse Brain Atlas project.
I. May 18th, 2011 Deadline for Call For Invited Posters for NIDA and NIAAA Genetics Satellite Miniconvention to World Congress on Psychiatric Genetics, Sept. 9-10, 2011, Omni Shoreham Hotel, Washington, DC
Day 1: NIDA/NIAAA Mini-convention on Genetics and Epigenetics of Substance Abuse, Friday Sept 9, and Call for Invited Posters
Day 2: NIAAA/NIDA Next generation sequencing technologies and Medical sequencing approaches for complex disorders
Day 1: NIDA/NIAAA Mini-convention on Genetics and Epigenetics of Substance Abuse, Friday Sept 9, and Call for Invited Posters
This satellite symposium to the World Congress on Psychiatric Genetics sponsored by the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism on Friday, September 9, 2011 at the Omni Shoreham Hotel, Washington, DC highlights recent advances in the field of the genetics and epigenetics of substance abuse. The impact of co-morbid psychiatric disorders on the genetics of substance abuse will also be discussed. The invited speakers are Ken Kendler, Laura Bierut, Howard Edenberg, Joel Gelernter, Paul Kenny, and Eric Nestler. Eric Green, the Director of the National Human Genome Research Institute will be the keynote speaker. Eric Green will speak about future directions for genetic and genomic research at NIH.
As part of the NIDA/NIAAA Mini-convention on Genetics and Epigenetics of Substance Abuse, Friday Sept 9, a call for invited posters on the genetics and epigenetics of substance abuse with or without co-morbid disorders is also being made for this meeting. An honorarium of $250 will be given to each of the 40 scientists whose abstracts are accepted and attend the meeting. Submissions will be reviewed on a competitive basis by NIDA and NIAAA program staff. The deadline for submission is May 18, 2011 by the close of business day. Please submit abstracts and CV to Posterabstracts@seiservices.com.
To register for the meeting go to http://www.seiservices.com/nida/1014096/.
Please also note that World Congress of Psychiatric Genetics is also providing Travel Awards to attend the 2011 World Congress of Psychiatric Genetics in Washington, D.C. for Alcohol and Substance Abuse Abstracts. The deadline to submit abstracts in this category only and travel award applications is Wednesday, June 1, 2011 at 5:00 pm, EST.
A new program was developed to highlight poster presentations for abstracts relating to alcohol and substance abuse. At the XIX World Congress in September, there will be an evening dedicated to these posters. The poster presentations will be given by travel award recipients. To be a part of this great new program, you must apply for a travel award specifically for this event. To apply, please send your CV, mentor letter and abstract to:
Anne O’Shea
Anne_O'Shea@hms.harvard.edu
Fax: 774-826-1758
Day 2: NIAAA/NIDA Next generation sequencing technologies and Medical sequencing approaches for complex disorders The purpose of this workshop is to develop consensus research strategy based on new developments in sequencing technologies or next generation sequencing (NGS) technologies. The production of large numbers of low cost sequence data makes the NGS platform useful for many applications especially human genomics. The application of NGS technologies to the identification of genes conferring vulnerability to alcohol dependence and substance abuse will be discussed.
o For more information contact:
Abbas Parsian, Ph.D.
Program Director, Human Genetics/Genomics
Division of Neuroscience & Behavior
NIAAA/NIH
5635 Fishers Lane, RM 2063
Bethesda, MD 20892-9304
Phone: 301-443-5733
Fax: 301-443-1650
E-mail: parsiana@mail.nih.gov
Federal Express mail delivery:
Rockville, MD 20852-1705
For more information contact:
Jonathan D. Pollock, Ph.D.
Chief
Genetics and Molecular Neurobiology Research Branch
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Blvd. Rm 4103
Bethesda, MD 20892
(For Fedex Delivery the address is Rockville, MD 20852)
tel. 301-435-1309
fax. 301-594-6043
email. jpollock@mail.nih.gov
II. NIDA Satellite Meeting at CPDD: Fundamental Genetics in Drug Abuse and Addiction
Friday, June 17, 2011, 8:00 AM - 4:00 PM http://www.cpdd.vcu.edu/Pages/satellitemeetings2011.html
Are you curious about new genetics findings in drug abuse? Want to better understand and appreciate this emerging literature? Perhaps incorporate genetics techniques in your own research? Maybe you are thinking of multidisciplinary training that includes population or molecular genetics. How might you go about establishing collaborations with genetics experts? Do you want to know about accessing informational resources, e.g., are there polymorphisms for this gene? What genes have been associated with this behavior? Is a knock-out mouse available? For additional information, please contact mlynch1@nida.nih.gov
III. Save the Date for NIDA Mini-Convention
Friday November 11, 2011
Washington, DC
National Institute on Drug Abuse Frontiers in Addiction Research Mini-Convention
The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session for early career investigators. The agenda this year includes:
8:00 – 8:15 Welcome: NIDA Director
8:15 – 9:35 Autism, Addiction, and MeCP2
9:35-10:10 Jacob P. Waletzky Memorial Lecture
10:30-12:15 Synapse Organization and Plasticity in Drug Addiction
12:15- 2:15 Early Career Investigators Poster Session
2:15-4:10 Using Optogenetic Tools to Shed Light on the Neural Mechanisms of Addiction
4:20-5:40 Neurobiology of Behavioral and Emotional Regulation/Dysregulation
Seating is limited. Please register online: https://seiservices.com/nida/frontiers2011/
IV. Upcoming Request for Applications (RFAs) Please read announcements for details.
The Placebo Effect: Mechanisms and Methodology RFA-DA-12-003 (R01)
RFA-DA-12-004 (R21)
Application Receipt Date(s): May 24, 2011
2011 NIDA Avant-Garde Award Program for HIV/AIDS Research RFA-DA-11-002 (DP1)
Application Receipt Date(s): May 26, 2011
Exploring Drugs of Abuse and Transgenerational Phenotypes
RFA-DA-12-006 (R01)
National Institute on Drug Abuse
Application Receipt Date(s): July 29, 2011
Medications Development Program Projects for Substance-Related Disorders RFA-DA-12-005 (P01)
National Institute on Drug Abuse
Application Receipt Date(s): July 29, 2011
HIV/AIDS Implementation Science Targeting Drug Using Populations: A Collaboration with PEPFAR RFA-DA-12-002 (R01)
Application Receipt Date(s): August 01, 2011
NIH Blueprint for Neuroscience Research Grand Challenge: Developing Novel Drugs for Disorders of the Nervous System RFA-NS-12-002 (U01)
National Institutes of Health (NIH) (http://www.nih.gov)
Application Receipt Date: August 10, 2010
Systems Biology Approaches in HIV/AIDS and Substance Use RFA-DA-12-009 (R01)
Application Receipt Date: August 17, 2011
V.
Numerous synergistic research efforts across disciplinary borders, particularly between medical imaging scientists and neurobiologists, have produced stunning advances in understanding the brain in health and disease. A collaborative NIH symposium will bring together leaders in medical imaging science to showcase cutting-edge technologies and the promise that imaging continues to hold for transforming human neuroscience research.
NIH’s National Center for Research Resources (NCRR) in collaboration with the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH), presents:
Advanced Medical Imaging Developments and Applications for Neuroscience Research
Thursday, June 9, 2011
8:15 a.m. – 4:40 p.m.
Lister Hill Auditorium, Building 38A
National Library of Medicine
National Institutes of Health
38 Center Drive
Bethesda, MD 20892
Join NIH staff, neurobiologists and medical imaging scientists for a free symposium to explore and discuss:
· Current medical imaging technologies
· Applications of medical imaging in brain disease and disorders
· Research collaboration opportunities between neurobiologists and medical imaging scientists and ways to facilitate such efforts
Register online by May 26. For logistical information, contact Liz Dolan at 301-650-8660 or edolan@palladianpartners.com. For program information, contact Christina Liu at 301-435-0905 or christina.liu@nih.gov.
VI. Website Available for Studying Co-expression Patterns of Genes Implicated in Addiction: Leveraging the genome-scale, high resolution expression maps created within the Allen Mouse Brain Atlas project.
Investigators from the Allen Brain Institute and Cold Spring Harbor Laboratory have teamed to study expression patterns of sets of genes related to addiction throughout the brain. They developed software tools to compute the similarity between expression patterns of pairs of genes across the whole brain, and to rank individual genes according to how well their expression is localized in a given anatomical structure. The co-expression graphs and localization scores can be exploited to cluster the list of addiction-related genes into smaller lists and to study the relationship between expression of genes and brain regions defined by classical neuroanatomy. Search tools, and more information on the project can be accessed at http://addiction.brainarchitecture.org/. User comments, suggestions, and questions are encouraged through email with the subject heading “co-expression feedback” to kskinner@mail.nih.gov
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services
TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email
- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment